These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1661367)

  • 1. A prototype beam delivery system for the proton medical accelerator at Loma Linda.
    Coutrakon G; Bauman M; Lesyna D; Miller D; Nusbaum J; Slater J; Johanning J; Miranda J; DeLuca PM; Siebers J
    Med Phys; 1991; 18(6):1093-9. PubMed ID: 1661367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A beam intensity monitor for the Loma Linda cancer therapy proton accelerator.
    Coutrakon G; Miller D; Kross BJ; Anderson DF; DeLuca P; Siebers J
    Med Phys; 1991; 18(4):817-20. PubMed ID: 1656180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial beam size study for passive scatter proton therapy. II. Changes in delivered depth dose profiles.
    Polf JC; Harvey MC; Smith AR
    Med Phys; 2007 Nov; 34(11):4219-22. PubMed ID: 18072486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spill-to-spill and daily proton energy consistency with a new accelerator control system.
    Moyers MF; Ghebremedhin A
    Med Phys; 2008 May; 35(5):1901-5. PubMed ID: 18561665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A performance study of the Loma Linda proton medical accelerator.
    Coutrakon G; Hubbard J; Johanning J; Maudsley G; Slaton T; Morton P
    Med Phys; 1994 Nov; 21(11):1691-701. PubMed ID: 7891629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivities in the production of spread-out Bragg peak dose distributions by passive scattering with beam current modulation.
    Lu HM; Brett R; Engelsman M; Slopsema R; Kooy H; Flanz J
    Med Phys; 2007 Oct; 34(10):3844-53. PubMed ID: 17985630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose error analysis for a scanned proton beam delivery system.
    Coutrakon G; Wang N; Miller DW; Yang Y
    Phys Med Biol; 2010 Dec; 55(23):7081-96. PubMed ID: 21076200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced treatment planning methods for efficient radiation therapy with laser accelerated proton and ion beams.
    Schell S; Wilkens JJ
    Med Phys; 2010 Oct; 37(10):5330-40. PubMed ID: 21089768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton beam therapy: a promising method of locoregional cancer control.
    Slater JM; Preston W
    Compr Ther; 1990 Jan; 16(1):3-6. PubMed ID: 2154365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facility overview for a proton beam treatment center.
    Lesyna D
    Technol Cancer Res Treat; 2007 Aug; 6(4 Suppl):41-8. PubMed ID: 17668951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The M. D. Anderson proton therapy system.
    Smith A; Gillin M; Bues M; Zhu XR; Suzuki K; Mohan R; Woo S; Lee A; Komaki R; Cox J; Hiramoto K; Akiyama H; Ishida T; Sasaki T; Matsuda K
    Med Phys; 2009 Sep; 36(9):4068-83. PubMed ID: 19810479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a beam line at the Fermi National Accelerator Laboratory for proton radiography.
    Curry J; Steward VW
    Med Phys; 1978; 5(3):188-94. PubMed ID: 672810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a hospital-based proton beam treatment center.
    Slater JM; Miller DW; Archambeau JO
    Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):761-75. PubMed ID: 2832357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast range switching of passively scattered proton beams using a modulation wheel and dynamic beam current modulation.
    Sánchez-Parcerisa D; Pourbaix JC; Ainsley CG; Dolney D; Carabe A
    Phys Med Biol; 2014 Apr; 59(7):N19-26. PubMed ID: 24625619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential role of proton beams in radiation oncology.
    Loeffler JS; Smith AR; Suit HD
    Semin Oncol; 1997 Dec; 24(6):686-95. PubMed ID: 9422264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial correlation of proton irradiation-induced activity and dose in polymer gel phantoms for PET/CT delivery verification studies.
    Lopatiuk-Tirpak O; Su Z; Li Z; Hsi W; Meeks S; Zeidan O
    Med Phys; 2011 Dec; 38(12):6483-8. PubMed ID: 22149831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On-line monitoring of radiotherapy beams: experimental results with proton beams.
    Litzenberg DW; Roberts DA; Lee MY; Pham K; Vander Molen AM; Ronningen R; Becchetti FD
    Med Phys; 1999 Jun; 26(6):992-1006. PubMed ID: 10436901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of optically stimulated luminescence dosimeters in the spread-out Bragg peak region of clinical proton beams.
    Kerns JR; Kry SF; Sahoo N
    Med Phys; 2012 Apr; 39(4):1854-63. PubMed ID: 22482607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerator-based epithermal neutron beam design for neutron capture therapy.
    Yanch JC; Zhou XL; Shefer RE; Klinkowstein RE
    Med Phys; 1992; 19(3):709-21. PubMed ID: 1324392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.